World Wires · story 23970 · unverified · 1 source(s)

Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission

RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a preclinical-stage medical device and reg

Open in the desk

Coverage

• Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission GlobeNewswire: public companies · tier D · clear net · 2026-10-06 12:30 UTC

What this site indexes